Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 study of E6005 in Japanese adults with atopic dermatitis
jRCT2080221229Phase 2
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lotamilast in atopic dermatitis (AD), sponsored by Eisai Co., Ltd.
02
Drugs
lotamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080221229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221229.